These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1543872)

  • 1. Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease.
    Shigesawa T; Sato C; Marumo F
    J Gastroenterol Hepatol; 1992; 7(1):7-11. PubMed ID: 1543872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of measuring plasma concentrations of glutamine and glutamate in alcoholic liver diseases.
    Tominaga T; Suzuki H; Mizuno H; Kouno M; Suzuki M; Kato Y; Sato A; Okabe K; Miyashita M
    Alcohol Alcohol Suppl; 1993; 1A():103-9. PubMed ID: 7908196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic glutathione content in patients with alcoholic and non alcoholic liver diseases.
    Altomare E; Vendemiale G; Albano O
    Life Sci; 1988; 43(12):991-8. PubMed ID: 3172971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oxidative stress and antioxidant defense in alcoholic liver disease and chronic hepatitis C].
    Pár A; Róth E; Rumi G; Kovács Z; Nemes J; Mózsik G
    Orv Hetil; 2000 Jul; 141(30):1655-9. PubMed ID: 10962902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug metabolism in liver disease. Identification of patients with impaired hepatic drug metabolism.
    Farrell GC; Cooksley WG; Hart P; Powell LW
    Gastroenterology; 1978 Oct; 75(4):580-8. PubMed ID: 710827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood antioxidant levels in patients with alcoholic liver disease correlate with the degree of liver impairment and are not specific to alcoholic liver injury itself.
    Van de Casteele M; Zaman Z; Zeegers M; Servaes R; Fevery J; Nevens F
    Aliment Pharmacol Ther; 2002 May; 16(5):985-92. PubMed ID: 11966508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease.
    Müller C; Knoflach P; Zielinski CC
    Hepatology; 1989 Dec; 10(6):928-32. PubMed ID: 2583687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage--a preliminary report.
    Farinati F; Cardin R; de Maria N; Lecis PE; Della Libera G; Burra P; Marafin C; Sturniolo GC; Naccarato R
    Biol Trace Elem Res; 1995; 47(1-3):193-9. PubMed ID: 7779547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hepatic glutathione content in liver diseases.
    Poulsen HE; Ranek L; Andreasen PB
    Scand J Clin Lab Invest; 1981 Oct; 41(6):573-6. PubMed ID: 7336124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma levels of soluble tumor necrosis factor receptors p55 and p75 in patients with alcoholic liver disease of increasing severity.
    Naveau S; Emilie D; Balian A; Grangeot-Keros L; Borotto E; Portier A; Giraud V; Capron F; Galanaud P; Chaput JC
    J Hepatol; 1998 May; 28(5):778-84. PubMed ID: 9625312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoacid imbalance ratio in liver disease.
    Maqsood R; Zuberi SJ
    J Pak Med Assoc; 1976 Jun; 26(6):145-6. PubMed ID: 826659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship of blood trace elements to liver damage, nutritional status, and oxidative stress in chronic nonalcoholic liver disease.
    Loguercio C; De Girolamo V; Federico A; Feng SL; Crafa E; Cataldi V; Gialanella G; Moro R; Del Vecchio Blanco C
    Biol Trace Elem Res; 2001 Sep; 81(3):245-54. PubMed ID: 11575681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histochemical study of hyaluronate in alcoholic liver disease.
    Urashima S; Tsutsumi M; Shimanaka K; Ueshima Y; Tsuchishima M; Itoh T; Kawahara H; Takase S
    Alcohol Clin Exp Res; 1999 Apr; 23(4 Suppl):56S-60S. PubMed ID: 10235280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The importance of thyroid hormone determination in the course of acute and chronic liver diseases].
    Giudici Cipriani A; Marenco G; Artom A; Menardo G; Colombo P; Rembado R; Barbetti V
    Minerva Med; 1981 Oct; 72(40):2669-74. PubMed ID: 7290469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum selenium levels and oxidative balance as differential markers in hepatic damage caused by alcohol.
    Rua RM; Ojeda ML; Nogales F; Rubio JM; Romero-Gómez M; Funuyet J; Murillo ML; Carreras O
    Life Sci; 2014 Jan; 94(2):158-63. PubMed ID: 24157457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma fibronectin concentrations in patients with liver diseases.
    Gluud C; Dejgaard A; Clemmensen I
    Scand J Clin Lab Invest; 1983 Oct; 43(6):533-7. PubMed ID: 6658370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [1-14C]Ethanol breath test in alcoholic liver disease.
    MacDougall BR; Dordoni B; Thompson RP; Davis M; Williams R
    Clin Chim Acta; 1978 May; 86(1):121-7. PubMed ID: 657531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of hepatitis GB virus C infection in alcoholic liver disease.
    Tsutsumi M; Sawada M; Takase S; Chen WB; Ueshima Y; Tsuchishima M; Shimanaka K; Itoh T; Kawahara H
    Alcohol Clin Exp Res; 1997 Dec; 21(9):1722-5. PubMed ID: 9438537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease.
    Grieco A; Matera A; Di Rocco P; Marcoccia S; Giancaterini A; Alfei B; Addolorato G; Varlese F; Gasbarrini G
    Hepatogastroenterology; 1998; 45(23):1731-6. PubMed ID: 9840137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microheterogeneity of the carbohydrate moiety of human alpha 1-acid glycoprotein in two benign liver diseases: alcoholic cirrhosis and acute hepatitis.
    Biou D; Chanton P; Konan D; Seta N; N'Guyen H; Feger J; Durand G
    Clin Chim Acta; 1989 Dec; 186(1):59-66. PubMed ID: 2612011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.